BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical is pleased to announce the completion of patient enrollment in its REFORM clinical trial, officials of Cook Medical reported today. The REFORM trial is designed to evaluate Cook’s advanced Formula™ Balloon Expandable Stent for the treatment of renal artery stenosis, a narrowing of the renal artery that can result in hypertension, renal atrophy, and kidney failure if left untreated.
